KEGG   DRUG: Ribavirin
Entry
D00423                      Drug                                   
Name
Ribavirin (JP18/USP/INN);
Copegus (TN);
Rebetol (TN);
Ribasphere (TN);
Virazole (TN)
  Abbr
RBV
Product
  Generic
Formula
C8H12N4O5
Exact mass
244.0808
Mol weight
244.2047
Structure
Simcomp
Class
Antiviral
 DG01440  Arabinofuranosyl type antiviral
 DG03198  Anti-HCV agent
  DG02000  HCV NS5B polymerase inhibitor
Remark
Therapeutic category: 6250
ATC code: J05AP01
Product: D00423<JP/US>
Efficacy
Antiviral
  Disease
Chronic hepatitis C [DS:H00413]
RSV infection [DS:H00401]
Comment
In combination with peginterferon alfa-2a
Target
HCV NS5B polymerase [KO:K22472]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko05160  Hepatitis C
Interaction
Structure map
map07044  Antiviral agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AP Antivirals for treatment of HCV infections
     J05AP01 Ribavirin
      D00423  Ribavirin (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-hepatitis C (HCV) Agents
   Ribavirin
    D00423  Ribavirin (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D00423  Ribavirin (JP18/USP/INN)
Drug groups [BR:br08330]
 Antiviral
  DG01440  Arabinofuranosyl type antiviral
   D00423  Ribavirin
  DG03198  Anti-HCV agent
   DG02000  HCV NS5B polymerase inhibitor
    D00423  Ribavirin
Drug classes [BR:br08332]
 Antiviral
  DG03198  Anti-HCV agent
   D00423  Ribavirin
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HCV NS5A/NS5B inhibitor
    D00423  Ribavirin (JP18/USP/INN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
 Antivirals
  Genome replication inhibitor
   HCV NS5A/NS5B inhibitor
    D00423  Ribavirin (JP17/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00423  Ribavirin
  D00423  Ribavirin capsules
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00423
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D00423
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D00423
Other DBs
CAS: 36791-04-5
PubChem: 7847489
ChEBI: 63580
PDB-CCD: RBV[PDBj]
LigandBox: D00423
NIKKAJI: J17.798I
KCF data

ATOM        17
            1   N4y N    25.5905  -16.0641
            2   N5x N    26.7827  -16.9056
            3   C1y C    24.3282  -16.4848
            4   C8x C    26.0814  -14.7316
            5   C8y C    27.9047  -16.0641
            6   O2x O    23.1360  -15.6433
            7   C1y C    23.8373  -17.8173
            8   N5x N    27.4840  -14.7316
            9   C5a C    29.1670  -16.6251
            10  C1y C    22.0140  -16.4848
            11  C1y C    22.4347  -17.8173
            12  O1a O    24.6788  -18.9393
            13  N1a N    29.1673  -18.0277
            14  O5a O    30.2891  -15.8537
            15  C1b C    20.6815  -16.0641
            16  O1a O    21.6633  -18.9393
            17  O1a O    19.6297  -16.9757
BOND        18
            1     1   2 1
            2     3   1 1 #Up
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     5   9 1
            9     6  10 1
            10    7  11 1
            11    7  12 1 #Down
            12    9  13 1
            13    9  14 2
            14   10  15 1 #Up
            15   11  16 1 #Down
            16   15  17 1
            17    5   8 1
            18   10  11 1

» Japanese version   » Back

DBGET integrated database retrieval system